The global preparative and process chromatography market was valued at USD 9.5 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 9.08% during the forecast period. Several factors are contributing to the growth of this market, particularly the increasing demand for and approval of monoclonal antibodies in the pharmaceutical and biotechnology sectors. Monoclonal antibodies, which are widely used in the treatment of diseases like cancer and autoimmune disorders, require advanced purification techniques such as chromatography to ensure their efficacy and safety. As the demand for these therapeutic antibodies rises, so does the need for efficient and precise chromatography systems to support their production.

In addition to the demand for monoclonal antibodies, the market is also driven by the expanding biopharmaceutical industry, which continues to innovate and grow, particularly in areas like biologics and gene therapies. The increasing complexity of biologic drugs requires the adoption of more sophisticated and reliable purification methods, further boosting the demand for advanced chromatography solutions. Chromatography techniques are essential in the biopharmaceutical industry for separating, purifying, and analyzing compounds, ensuring that drugs are safe for use and meet the required quality standards.

Moreover, there is a growing need for more efficient and cost-effective processes within the pharmaceutical and biotechnology industries. Companies are looking for ways to reduce production costs while maintaining high-quality standards, making preparative and process chromatography an essential tool. As companies focus on increasing productivity and reducing operational costs, innovations in chromatography products that offer faster processing, greater throughput, and improved separation capabilities are playing a key role in shaping market trends.

Technological advancements in chromatography are expected to further accelerate market growth. In particular, the development of innovative chromatography products that offer enhanced performance and capabilities is helping to meet the evolving needs of the pharmaceutical and biopharmaceutical industries. For instance, in October 2021, CEM Corporation launched the Prodigy Preparative High-Performance Liquid Chromatography (HPLC) System, which offers elevated temperature capabilities to improve resolution and separation efficiency. This innovation enables more precise separation of compounds and enhances the overall efficiency of chromatography processes, helping businesses streamline their operations and meet the growing demand for high-quality biologic products.

Gather more insights about the market drivers, restrains and growth of the Preparative And Process Chromatography Market

Regional Insights

The global market for preparative and process chromatography is segmented into five key geographical regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. In 2022, North America held the dominant position in the global market, accounting for the largest market share of 31.43% of the overall revenue. This market dominance can be attributed to several key factors. First, the region boasts a high concentration of leading players in the pharmaceutical and biotechnology industries, which contribute to the growth of the market. These companies heavily invest in research and development (R&D) programs for disease management, which not only drives market growth but also leads to the development of innovative technologies and products. Moreover, advanced healthcare infrastructure, along with supportive reimbursement policies and government incentives, further enhances the growth prospects in North America.

Europe follows North America in market share, driven by the region's well-established pharmaceutical industry, which is actively adopting advanced purification technologies, including chromatography, for drug development and production. Moreover, Europe continues to invest heavily in R&D for biopharmaceutical production and process optimization, further bolstering its market position.

Asia Pacific

In contrast, the Asia Pacific region is poised to experience the fastest growth rate over the forecast period. This expected growth is primarily driven by the rapidly developing pharmaceutical and biotechnology sectors in countries such as China and India, which are becoming key hubs for pharmaceutical production and innovation. The Asia Pacific region also benefits from a large and diverse consumer base, especially in countries like China, where the biopharmaceutical market is growing at a robust pace due to increasing demand for biologics and vaccines.

Another key driver of the market's growth in the Asia Pacific region is the aging population, particularly in countries like Japan and China, where a growing elderly population is increasing the demand for advanced healthcare solutions, including biopharmaceuticals. This demographic shift will likely fuel the demand for chromatography products and technologies used in drug manufacturing and disease treatment.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global cancer stem cells market size was valued at USD 2.89 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030.

• The global DNA & gene chip market size was valued at USD 9.96 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 12.3% from 2024 to 2030.

Key Companies & Market Share Insights

The competitive landscape of the preparative and process chromatography market is marked by continuous innovation and product development. Leading companies in the market are increasingly focusing on launching advanced products and technologies to retain market share and address evolving customer demands. These companies are striving to develop innovative chromatography solutions that can cater to the growing global demand for efficient and cost-effective separation and purification technologies.

For instance, in August 2020, Thermo Fisher Scientific launched the Thermo Scientific Dionex Easion Ion Chromatographic System, a new product designed for water analysis. This system is aimed at reducing the total cost of ownership and maintenance, making it a more affordable solution for laboratories and industries. The launch of such products reflects the increasing demand for solutions that not only enhance analytical performance but also offer cost efficiency for businesses seeking to streamline their operations.

Similarly, in November 2020, Shimadzu Corporation introduced the “Advanced i-Series” HPLC system, an improved version of its flagship liquid chromatography model. This upgraded model is particularly designed to support remote work environments, reflecting the growing trend toward digitalization and automation in laboratories. By offering enhanced functionality, such as improved connectivity and ease of use, this system aligns with the increasing demand for flexible and scalable chromatography solutions, especially in the post-pandemic era where remote and hybrid working models are becoming more prevalent.

Some prominent players in the global preparative and process chromatography market include:

• GE Healthcare

• Danaher Corp.

• Merck KGaA

• Bio-Rad Laboratories Inc.

• Thermo Fisher Scientific Inc.

• Shimadzu Corp.

• Agilent Technologies

• Waters Corp.

• Novasep Holding S.A.S

Order a free sample PDF of the Preparative And Process Chromatography Market Intelligence Study, published by Grand View Research.